coronavirus updates

DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate

Read Article DBT-BIRAC has facilitated the establishment of ‘first-of-its-kind’ mRNA-based vaccine manufacturing platform in India. It has provided seed funding for the development of Gennova’s novel self-amplifying mRNA-based vaccine candidate for COVID19. In collaboration with HDT Biotech Corporation, Seattle, US, Gennova has developed an mRNA […]